EBRO 2017
• Use of concomitant chemotherapy – No = 19% – Yes = 81%
• Regimens
– Cisplatin 55% – Cis + 5FU 31% – 5FU + MMC 5% – Other 9%
Gaffney DK, et al. Int J Gynecol Cancer. 2009;19:163-7
Made with FlippingBook Learn more on our blog
• Use of concomitant chemotherapy – No = 19% – Yes = 81%
• Regimens
– Cisplatin 55% – Cis + 5FU 31% – 5FU + MMC 5% – Other 9%
Gaffney DK, et al. Int J Gynecol Cancer. 2009;19:163-7
Made with FlippingBook Learn more on our blog